Dr. Beth Mclellan, M.D.
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- Wayne State University School of Medicine (2007)
- Years since graduation
- 19
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 219
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Medical school: Wayne State University School of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
NY license 260468-1
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Montefiore Medical Center Bronx, NY
Medical groups
- Montefiore Medical Center (2,820 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 219
- Services billed
- 524
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 173 | 112 |
| Established patient office or other outpatient visit, 30-39 minutes | 79 | 49 |
| New patient office or other outpatient visit, 30-44 minutes | 37 | 37 |
| New patient office or other outpatient visit, 45-59 minutes | 30 | 30 |
| Destruction of precancer skin growth, 1 growth | 17 | 14 |
| Biopsy of related skin growth, first growth | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Triamcinolone Acetonide Other prescribers in New York, NY | 310 |
| Ketoconazole Other prescribers in New York, NY | 189 |
| Dupixent Pen (dupilumab) Other prescribers in New York, NY | 135 |
| Hydrocortisone Other prescribers in New York, NY | 110 |
| Halobetasol Propionate | 90 |
| Clobetasol Propionate Other prescribers in New York, NY | 71 |
| Mupirocin Other prescribers in New York, NY | 66 |
| Clindamycin Phosphate Other prescribers in New York, NY | 65 |
| Ammonium Lactate Other prescribers in New York, NY | 54 |
| Gabapentin Other prescribers in New York, NY | 52 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 8 payments worth $9,097 in total to this clinician.
| Janssen Biotech, Inc. | $5,397 |
|---|---|
| Janssen Scientific Affairs, LLC | $3,700 |
| Consulting Fee | $7,950 |
|---|---|
| Travel and Lodging | $1,147 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Aug 6, 2025 | Consulting Fee RYBREVANT · Oncology | $4,250 |
| Janssen Scientific Affairs, LLC Mar 24, 2025 | Consulting Fee RYBREVANT · Oncology | $2,220 |
| Janssen Biotech, Inc. May 2, 2025 | Travel and Lodging RYBREVANT · Oncology · travel to GRAPEVINE, TX · in-kind | $774 |
| Janssen Scientific Affairs, LLC Mar 24, 2025 | Consulting Fee RYBREVANT · Oncology | $740 |
| Janssen Scientific Affairs, LLC Aug 14, 2025 | Consulting Fee RYBREVANT · Oncology | $370 |
| Janssen Scientific Affairs, LLC Aug 14, 2025 | Consulting Fee RYBREVANT · Oncology | $370 |
| Janssen Biotech, Inc. May 2, 2025 | Travel and Lodging RYBREVANT · Oncology · travel to GRAPEVINE, TX · in-kind | $225 |
| Janssen Biotech, Inc. May 2, 2025 | Travel and Lodging RYBREVANT · Oncology · travel to GRAPEVINE, TX · in-kind | $148 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.